Holen Sie sich die Stockscreener-App
1.29
3.73%
-0.05
Handel nachbörslich:
1.26
-0.03
-2.33%
Schlusskurs vom Vortag:
$1.34
Offen:
$1.32
24-Stunden-Volumen:
653.88K
Relative Volume:
0.16
Marktkapitalisierung:
$22.47M
Einnahmen:
$128.60K
Nettoeinkommen (Verlust:
$-4.60M
KGV:
-2.0476
EPS:
-0.63
Netto-Cashflow:
$-3.74M
1W Leistung:
+37.50%
1M Leistung:
+47.26%
6M Leistung:
-27.53%
1J Leistung:
+43.33%
1-Tages-Spanne:
$1.26
$1.38
1-Wochen-Bereich:
$1.20
$2.00
52-Wochen-Spanne:
$0.702
$4.4899
Nexalin Technology Inc Stock (NXL) Company Profile
Firmenname
Nexalin Technology Inc
Sektor
Branche
Telefon
(832) 260-0222
Adresse
1776 YORKTOWN, HOUSTON
Vergleichen Sie NXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
1.29 | 23.34M | 128.60K | -4.60M | -3.74M | -0.63 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Nexalin Technology Inc Aktie (NXL) Neueste Nachrichten
Analyzing drawdowns of Nexalin Technology Inc. with statistical tools2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Analyzing Nexalin Technology Inc. with multi timeframe charts2025 Analyst Calls & Entry Point Strategy Guides - newser.com
Nexalin Technology Inc. stock momentum explainedEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Can Nexalin Technology Inc. stock outperform in 2025 bull marketQuarterly Risk Review & Low Drawdown Trading Strategies - newser.com
Nexalin Technology appoints Robert Rothstein to Scientific Advisory Board - TipRanks
Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer’s and Traumatic Brain Injury Programs - The Manila Times
Nexalin Technology Expands Scientific Advisory Board with - GlobeNewswire
Nexalin Names Robert Rothstein; Alzheimer's Trials Start Q4 2025 | NXL Stock News - Stock Titan
Will Nexalin Technology Inc. stock sustain high P E ratiosQuarterly Performance Summary & Long-Term Safe Return Strategies - newser.com
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Detecting support and resistance levels for Nexalin Technology Inc. Equity WarrantPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com
Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit - GlobeNewswire
Oct 22 Attendance — Nexalin at Maxim Growth Summit to Showcase DIFS Neurostimulation & Clinical Data - Stock Titan
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Ranking Nexalin Technology Inc. Equity Warrant among high performing stocks via toolsJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com
Top Penny Stocks To Follow Now – October 8th - Defense World
3 Penny Stocks to Watch Now, 10/9/25 - TipRanks
Why Is Nexalin Technology Stock (NXL) Down 20% Today? - TipRanks
Why Is Micro-Cap Stock Nexalin Technology Rallying On Wednesday? - Benzinga
Small-Cap Biotechs And AMD Make Waves With Big News - Finimize
Nexalin shares skyrocket after Alzheimer’s study shows strong cognitive gains - MSN
Is Nexalin’s Stock Set to Skyrocket? - StocksToTrade
Nexalin's Game-Changing Alzheimer's Breakthrough Ignites a Wild Pre-Market Rally – Is This the Next Big Biotech Winner? - RagingBull
Is Nexalin’s Device Driving Stock Surge? - timothysykes.com
Nexalin stock soars after Alzheimer’s treatment shows cognitive benefits By Investing.com - Investing.com Australia
Nexalin stock soars after Alzheimer’s treatment shows cognitive benefits - Investing.com
Nexalin Technology announces additional positive clinical results in Alzheimer's disease with Gen-2 Sync neurostimulation device - MarketScreener
Is Nexalin Technology Inc a good long term investmentTechnical Breakout Signals & Free High Profit Capital Plays - earlytimes.in
Nexalin Technology Announces Additional Positive Clinical - GlobeNewswire
Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device - Yahoo Finance
Nexalin Technology Inc Stock Analysis and ForecastTrendline Breakouts & The Best Picks Hiding in Plain Sight - earlytimes.in
Will New Product Launches Boost Swan Energy Limiteds Revenue in YEARIPO Market Watch & Build Wealth With Zero-Cost Tools - earlytimes.in
Why Nexalin Technology Inc. stock is trending among retail tradersJuly 2025 Review & Comprehensive Market Scan Reports - newser.com
Top chart patterns to watch in Nexalin Technology Inc. Equity WarrantGDP Growth & Step-by-Step Trade Execution Guides - newser.com
How moving averages guide Nexalin Technology Inc. tradingInsider Buying & Expert Verified Stock Movement Alerts - newser.com
Using Bollinger Bands to evaluate Nexalin Technology Inc. Equity Warrant2025 Major Catalysts & Weekly High Return Opportunities - newser.com
Technical signs of recovery in Nexalin Technology Inc. Equity WarrantEarnings Overview Report & Stock Market Timing Techniques - newser.com
Pattern recognition hints at Nexalin Technology Inc. upsideWeekly Profit Analysis & Community Supported Trade Ideas - newser.com
Published on: 2025-10-05 05:31:30 - newser.com
What does recent volatility data suggest for Nexalin Technology Inc.Quarterly Risk Review & Low Drawdown Trading Strategies - newser.com
How to use Fibonacci retracement on Nexalin Technology Inc. Equity WarrantWeekly Trade Review & Real-Time Stock Movement Alerts - newser.com
How to interpret RSI for Nexalin Technology Inc. Equity Warrant stockGap Up & Low Risk High Win Rate Stock Picks - newser.com
Volume spikes in Nexalin Technology Inc. stock – what they meanEarnings Summary Report & AI Driven Stock Movement Reports - newser.com
Finanzdaten der Nexalin Technology Inc-Aktie (NXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nexalin Technology Inc-Aktie (NXL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
| Owens David | Chief Medical Officer |
Oct 28 '24 |
Buy |
2.19 |
500 |
1,095 |
148,293 |
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):